Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release

被引:186
作者
Aghdam, Marjan Abri [1 ]
Bagheri, Roya [1 ]
Mosafer, Jafar [2 ,3 ]
Baradaran, Behzad [1 ]
Hashemzaei, Mahmoud [4 ]
Baghbanzadeh, Amir [1 ]
de la Guardi, Miguel [5 ]
Mokhtarzadeh, Ahad [1 ,6 ]
机构
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Torbat Heydariyeh Univ Med Sci, Sch Paramed Sci, Dept Med Biotechnol, Torbat Heydariyeh, Iran
[3] Mashhad Univ Med Sci, Sch Pharm, Nanotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran
[4] Zabol Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Zabol, Iran
[5] Univ Valencia, Dept Analyt Chem, Dr Moliner 50, E-46100 Valencia, Spain
[6] Higher Educ Inst Rab Rashid, Dept Biotechnol, Tabriz, Iran
关键词
Liposome; Thermosensitive; pH-sensitive; Polymer; Drug delivery; POLYMER-MODIFIED LIPOSOMES; N-ISOPROPYLACRYLAMIDE COPOLYMERS; CELL-PENETRATING PEPTIDE; DRUG-DELIVERY SYSTEMS; IN-VITRO EVALUATION; TEMPERATURE-TRIGGERED RELEASE; TUMOR-SPECIFIC THERAPY; ANTIGEN DELIVERY; GENE DELIVERY; ANTITUMOR-ACTIVITY;
D O I
10.1016/j.jconrel.2019.09.018
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Nanotechnology has recently gained lots of interest in drug delivery due to its potential to improve the therapeutic outcomes of various diseases. Particularly, a wide range of different nano-sized vesicles has been investigated for drug delivery. Among them, one of the most attractive and well-investigated nanocarriers are liposomes. Although liposomes have several advantages such as low toxicity, biodegradability and biocompatibility as well as accumulate in tumor site via enhanced permeability and retention (EPR) effect, inefficient drug delivery to the target cells could affect the therapeutic purpose of most of conventional liposomal formulations. Therefore, new systems of drug release including stimuli-responsive liposomal have been introduced for the improvement of the efficacy and release payloads in a site-specific manner. Stimuli-responsive liposomes stay stable in blood stream circulation but are activated in response to internal or external stimuli. This review highlights the development of thermosensitive and pH-sensitive liposomes, focusing on liposomal compositions and the effects of the synthetic polymers on their drug release behavior. Furthermore, in vitro and in vivo applications of these formulations will be discussed.
引用
收藏
页码:1 / 22
页数:22
相关论文
共 253 条
[1]
Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment [J].
Afsharzadeh, Maryam ;
Hashemi, Maryam ;
Mokhtarzadeh, Ahad ;
Abnous, Khalil ;
Ramezani, Mohammad .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (06) :1095-1110
[2]
Separation of liposome-entrapped mitoxantrone from nonliposomal mitoxantrone in plasma: Pharmacokinetics in mice [J].
Ahmad, A ;
Wang, YF ;
Ahmad, I .
LIPOSOMES, PT E, 2005, 391 :176-185
[3]
Formulation and Pharmacokinetics of Thermosensitive StealthA® Liposomes Encapsulating 5-Fluorouracil [J].
Al Sabbagh, Chantal ;
Tsapis, Nicolas ;
Novell, Anthony ;
Calleja-Gonzalez, Patricia ;
Escoffre, Jean-Michel ;
Bouakaz, Ayache ;
Chacun, Helene ;
Denis, Stephanie ;
Vergnaud, Juliette ;
Gueutin, Claire ;
Fattal, Elias .
PHARMACEUTICAL RESEARCH, 2015, 32 (05) :1585-1603
[4]
Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes [J].
Al-Ahmady, Zahraa S. ;
Hadjidemetriou, Marilena ;
Gubbins, James ;
Kostarelos, Kostas .
JOURNAL OF CONTROLLED RELEASE, 2018, 276 :157-167
[5]
Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[6]
SERUM-INDUCED LEAKAGE OF LIPOSOME CONTENTS [J].
ALLEN, TM ;
CLELAND, LG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 597 (02) :418-426
[7]
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects [J].
Alphandery, Edouard ;
Grand-Dewyse, Pierre ;
Lefevre, Raphael ;
Mandawala, Chalani ;
Durand-Dubief, Mickael .
EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (10) :1233-1255
[8]
Alvey C., 2010, ACOUST SOC AM, V127, P862
[9]
An X., 2017, NANOSTRUCTURES DRUG, P887